To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Biotech startup Adela procures $60m in Series A financing
Toronto-based biotechnology startup Adela has launched with a $60 million Series A financing. F-Prime led the round, with participation from OrbiMed, Deerfield Management, Decheng Capital and RA Capital Management.
